Non-specific plasma proteins and extracellular space

Non-specific plasma proteins and extracellular space refers to the physiological compartments and circulating proteins, such as albumin and alpha-1-acid glycoprotein, that interact with drugs without triggering a specific biological response (StatPearls, 2023). These components are fundamental to pharmacokinetics, as they determine the volume of distribution and the free fraction of a drug available to reach its intended therapeutic target (PubMed, PMID: 11588116). Most drugs bind reversibly to plasma proteins, which acts as a circulating reservoir and influences the drug's half-life and clearance (Merck Manual, 2024). The extracellular space, comprising the interstitial fluid and plasma, serves as the primary medium through which drugs travel from the bloodstream to tissues (Wikipedia, Extracellular fluid). While not a drug target for therapeutic modulation, these entities are critical considerations in drug design and dosing, particularly for drugs with narrow therapeutic windows where displacement from binding sites can lead to toxicity (NIH, Pharmacokinetics). Changes in the concentration of these proteins, often seen in liver or kidney disease, can significantly alter drug efficacy and safety profiles.

Other names

Plasma proteinsExtracellular fluidInterstitial spaceIntravascular compartmentSerum proteinsAlbumin binding sites

Non-specific reversible binding to plasma proteins (primarily albumin and alpha-1-acid glycoprotein) and distribution throughout the extracellular fluid volume via passive diffusion and bulk flow.